Isabel Hidalgo Parra
Hospital Italiano de Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Isabel Hidalgo Parra.
International Journal of Dermatology | 2004
Ricardo Galimberti; Eduardo Dos Ramos Farías; Isabel Hidalgo Parra; Luis Algranati; Alicia Kowalczuk; Nora Imperiali; Gustavo Greloni; Gastón Galimberti
Background Calcific uremic arteriolopathy is a rare and serious disorder characterized by systemic medial calcification of the arteries and tissue ischemia. Most often it is found in patients with chronic renal failure on dialysis and in renal transplant recipients with secondary hyperparathyroidism.
Anais Brasileiros De Dermatologia | 2006
Mariana Franco; Camila Giusti; Daniela Malieni; Damián Ferrario; Gastón Galimberti; Isabel Hidalgo Parra; Alicia Kowalczuk; Ricardo Galimberti
Sweets syndrome was described in 1964 by Robert Douglas Sweet, as an entity he named acute febrile neutrophilic dermatosis. It is characterized by five main features: 1) sudden appearance of erythematous and tender plaques on the face, neck and extremities; 2) fever; 3) polymorphonuclear leukocytes; 4) predominantly neutrophilic dense infiltrate in the dermis, and 5) rapid response to steroid therapy. Sweets syndrome can be classified into five groups: idiopathic, parainflammatory, paraneoplastic, drug-induced, and pregnancy-related. Twenty percent of cases are associated with malignancies; 85% out of them involve hematologic alignancies and the remaining 15%, solid tumors. A series of seven cases of Sweets syndrome associated with neoplasms which were diagnosed from 2002 to 2006 is presented. Six cases were related to oncohematologic diseases and one to solid tumors. These results highlight the importance of the diagnosis of the syndrome, since it may predict tumor relapse or underlying disease progression. The timely use of diagnostic and treatment methods may improve the quality of life of these patients. The fact that oncology patients take multiple medications (a colony-stimulating factor) which may be associated with the onset of this entity must also be considered in excluding possible causes.
International Journal of Dermatology | 2008
Isabel Hidalgo Parra; Ricardo Galimberti; Gastón Galimberti; Bárbara Guanella; Alicia Kowalczuk
Background Infections are the leading cause of morbidity and mortality in transplanted patients. The increasing number of immunocompromised patients has not only augmented infections by specific pathogens, but also by opportunistic microbial agents.
International Journal of Dermatology | 1999
Ricardo Galimberti; Isabel Hidalgo Parra; Nora Imperiali; Guillermo Rosa Diez; Alicia Kowalczuk; Luis Algranati; Gastón Galimberti
Piel | 2010
Isabel Hidalgo Parra; Ana Rita Rodríguez de Valentiner; Sandra Sapia; José Carlos Moreno Giménez
Medicina cutánea ibero-latino-americana | 2007
Cecilia Navarro Tuculet; Isabel Hidalgo Parra; Paula A Enz; Gastón Galimberti; Ricardo Galimerti
Arch. argent. dermatol | 2005
Ricardo Galimberti; Isabel Hidalgo Parra; Daniela Malieni; Gastón Galimberti; Alicia Kowalczuk
Piel | 2010
Isabel Hidalgo Parra; Ana Rita Rodríguez de Valentiner; Sandra Sapia; José Carlos Moreno Giménez
Dermatología Argentina | 2010
Mariana Franco; Isabel Hidalgo Parra; Nuria Bibiloni; Alicia Kowalczuk; Ricardo Galimberti
Dermatología Argentina | 2010
Isabel Hidalgo Parra; Gerardo Martin Garaguso; Gastón Galimberti; Ricardo Galimberti; Alicia Kowalczuk